-
EP2769715
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2769715
| EP2769715 - Methods for treating autoimmune disorders, and reagents related thereto [Right-click to bookmark this link] | Status | The application has been refused Status updated on 23.03.2018 Database last updated on 16.07.2024 | Most recent event Tooltip | 23.03.2018 | Refusal of application | published on 25.04.2018 [2018/17] | Applicant(s) | For all designated states TRUSTEES OF TUFTS COLLEGE Ballou Hall Medford, MA 02155 / US | For all designated states Brigham and Women's Hospital, Inc. 75 Francis Street Boston, MA 02115 / US | [2014/35] | Inventor(s) | 01 /
Bachovchin, William W. 75 Cambridge Parkway Apt. E609 Cambridge, Massachusetts 02142 / US | 02 /
Kuchroo, Vijay, K. 30 Fairhaven Road Newton, Massachusetts 02459-3424§ / US | [2014/45] |
| Former [2014/35] | 01 /
Bachovchin, William W. 7 Warwick Street Melrose, Massachusetts 02176 / US | ||
| 02 /
Kuchroo, Vijay, K. 30 Fairhaven Road Newton, Massachusetts 02459-3424§ / US | Representative(s) | Gibbs, Richard Marks & Clerk LLP The Beacon 176 St Vincent Street Glasgow G2 5SG / GB | [N/P] |
| Former [2014/35] | Gibbs, Richard Marks & Clerk LLP Aurora 120 Bothwell Street Glasgow G2 7JS / GB | Application number, filing date | 14161169.9 | 26.11.2002 | [2014/35] | Priority number, date | US20010333691P | 26.11.2001 Original published format: US 333691 P | [2014/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2769715 | Date: | 27.08.2014 | Language: | EN | [2014/35] | Type: | A3 Search report | No.: | EP2769715 | Date: | 17.09.2014 | [2014/38] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.08.2014 | Classification | IPC: | A61K31/00, A61K38/00, A61K31/69, A61P37/06, A61P3/10 | [2014/38] | CPC: |
A61K31/40 (EP,US);
A61K31/401 (EP,US);
A61K31/69 (EP,US);
A61K38/005 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/18 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/18 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2015/17] |
| Former [2014/35] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR | Title | German: | Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien | [2014/35] | English: | Methods for treating autoimmune disorders, and reagents related thereto | [2014/35] | French: | Procédés pour le traitement de troubles auto-immuns et réactifs associés | [2014/35] | Examination procedure | 13.03.2015 | Examination requested [2015/17] | 17.03.2015 | Amendment by applicant (claims and/or description) | 30.05.2016 | Despatch of a communication from the examining division (Time limit: M06) | 24.10.2016 | Reply to a communication from the examining division | 24.11.2017 | Application refused, date of legal effect [2018/17] | 24.11.2017 | Date of oral proceedings | 07.12.2017 | Despatch of communication that the application is refused, reason: substantive examination [2018/17] | 07.12.2017 | Minutes of oral proceedings despatched | Parent application(s) Tooltip | EP02795710.9 / EP1487471 | Fees paid | Renewal fee | 21.03.2014 | Renewal fee patent year 03 | 21.03.2014 | Renewal fee patent year 04 | 21.03.2014 | Renewal fee patent year 05 | 21.03.2014 | Renewal fee patent year 06 | 21.03.2014 | Renewal fee patent year 07 | 21.03.2014 | Renewal fee patent year 08 | 21.03.2014 | Renewal fee patent year 09 | 21.03.2014 | Renewal fee patent year 10 | 21.03.2014 | Renewal fee patent year 11 | 21.03.2014 | Renewal fee patent year 12 | 10.11.2014 | Renewal fee patent year 13 | 10.11.2015 | Renewal fee patent year 14 | 10.11.2016 | Renewal fee patent year 15 | Penalty fee | Additional fee for renewal fee | 30.11.2017 | 16 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]WO02068420 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [XP] 1-10 * abstract * * page 1, line 1 - line 23 * * page 103, line 20 - page 105, line 19; claims 1,16 *; | [X]WO0172290 (PROBIODRUG GES FUER ARZNEIM [DE], et al) [X] 1-10 * abstract * * page 2, line 9 - page 3, line 13 * * page 4, line 5 - page 6, line 22; claim - *; | [A]WO9740832 (KNOELL HANS FORSCHUNG EV [DE], et al) [A] 1-10 * the whole document *; | [A]WO9938501 (TRUSTEES OF TUFTS UNIVERSITY [US], et al) [A] 1-10 * abstract * * page 3, line 26 - page 4, line 11; example -; claim - *; | [A]WO9116339 (NEW ENGLAND MEDICAL CENTER INC [US], et al) [A] 1-10 * abstract * * page 2, line 4 - line 13; example 2 * * page 17, line 31 - page 18, line 10; claim - *; | [A]WO9308259 (NEW ENGLAND MEDICAL CENTER INC [US], et al) [A] 1-10 * abstract * * page 2, line 7 - line 17; example -; table 1 * * page 21, line 4 - line 19; claim - *; | [A]WO0134594 (GUILFORD PHARM INC [US], et al) [A] 1-10 * abstract * * page 2, line 6 - line 14; claim - *; | [A]WO0010549 (POINT THERAPEUTICS INC [US], et al) [A] 1-10 * abstract * * page 4, line 14 - line 32; example -; claim - *; | [AP]WO0189569 (INST MEDIZINTECHNOLOGIE MAGDEB [DE], et al) [AP] 1-10 * abstract * * page 2, paragraph L * * page 4, paragraph 1; example - * * claims 1,2,5 * | by applicant | EP0363284 | EP0364344 | WO8810266 | EP0393457 | US4935493 | US5462928 | US5543396 | US5296604 | US4522752 | US5061811 | - XU, DIABETES, (1999), vol. 48, pages 2270 - 2276 | - STOFFERS ET AL., DIABETES, (2000), vol. 49, pages 741 - 748 | - SELCIYA, BIOCHEM BIOPHYS RES COMM, (2000), vol. 278, no. 1, pages 211 - 216 | - DRUCKER ET AL., PNAS, (1996), vol. 93, page 7911 | - DELGADO, NAT MED, (2001), vol. 7, no. 5, pages 563 - 568 | - GOMARIZ, CURR PHANN DES, (2001), vol. 7, no. 2, pages 89 - 111 | - KUBIAK ET AL., PEPTIDE RES, (1994), vol. 7, page 153 | - ANGELASTRO ET AL., J. MED CHEM., (1990), vol. 33, pages 11 - 13 | - EWOLDT ET AL., MOLECULAR IMMUNOLOGY, (1992), vol. 29, no. 6, pages 713 - 721 | - HERNANDEZ ET AL., JOURNAL OF MEDICINAL CHEMISTRY, (1992), vol. 35, no. 6, pages 1121 - 1129 | - VLASALC ET AL., J VIROLOGY, (1989), vol. 63, no. 5, pages 2056 - 2062 | - HUDIG ET AL., J IMMUNOL, (1991), vol. 147, no. 4, pages 1360 - 1368 | - ODAKE ET AL., BIOCHEMISTRY, (1991), vol. 30, no. 8, pages 2217 - 2227 | - VIJAYALAKSHMI ET AL., BIOCHEMISTRY, (1991), vol. 30, no. 8, pages 2175 - 2183 | - KAM ET AL., THROMBOSIS AND HAEMOSTASIS, (1990), vol. 64, no. 1, pages 133 - 137 | - POWERS ET AL., J CELL BIOCHEM, (1989), vol. 39, no. 1, pages 33 - 46 | - POWERS ET AL., Proteinase Inhibitors, ELSEVIER, (1986), pages 55 - 152 | - POWERS ET AL., BIOCHEMISTRY, (1990), vol. 29, no. 12, pages 3108 - 3118 | - OWEIDA ET AL., THROMBOSIS RESEARCH, (1990), vol. 58, no. 2, pages 391 - 397 | - HUDIG ET AL., MOLECULAR IMMUNOLOGY, (1989), vol. 26, no. 8, pages 793 - 798 | - ORLOWSKI ET AL., ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, (1989), vol. 269, no. 1, pages 125 - 136 | - ZUNINO ET AL., BIOCHIMICA ET BIOPHYSICA ACTA, (1988), vol. 967, no. 3, pages 331 - 340 | - KAM ET AL., BIOCHEMISTRY, (1988), vol. 27, no. 7, pages 2547 - 2557 | - PARKES ET AL., BIOCHEM J., (1985), vol. 230, pages 509 - 516 | - GREEN ET AL., J. BIOL. CHEM., (1981), vol. 256, pages 1923 - 1928 | - ANGLIKER ET AL., BIOCHEM. J., (1987), vol. 241, pages 871 - 875 | - PURI ET AL., ARCH. BIOCHEM. BIOPHYS., (1989), vol. 27, pages 346 - 358 | - HANADA ET AL., Proteinase Inhibitors: Medical and Biological Aspects, SPRINGER-VERLAG, (1983), pages 25 - 36 | - KAJIWARA ET AL., BIOCHEM. INT., (1987), vol. 15, pages 935 - 944 | - RAO ET AL., THROMB. RES., (1987), vol. 47, pages 635 - 637 | - TSUJINALCA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1988), vol. 153, pages 1201 - 1208 | - NONAKA, J. ANTIBIOT (TOKYO, (1997), vol. 50, no. 8, pages 646 - 652 | - REINHOLD ET AL., IMMUNOLOGY, (1997), vol. 91, no. 3, pages 354 - 360 | - JIANG ET AL., RES. VIROL., (1997), vol. 148, no. 4, pages 255 - 266 | - TANAKA ET AL., INT J IMMUNOPHARMACOL, (1997), vol. 19, no. 1, pages 15 - 24 | - BODUSZEK ET AL., J MED CHEM, (1994), vol. 37, no. 23, pages 3969 - 3976 | - UMEZAWA ET AL., J ANTIBIOTICS, (1984), vol. 37, pages 422 - 425 | - SHIMAZAWA ET AL., BIOORG MED CHEM LETT, (1999), vol. 9, no. 4, pages 559 - 562 | - AUGUSTYNS ET AL., CUIT MED CHEM, (1999), vol. 6, no. 4, pages 311 - 327 | - BIOCHEMISTRY, (1972), vol. 11, pages 1726 - 1732 | - K. D. KOPPLE, Peptides and Amino Acids, W. A. BENJAMIN INC., (1966), page 2,33 | - RADHALCRISHNA ET AL., J. ORG. CHEM., (1979), vol. 44, page 1746 | - Y.K. SHUE ET AL., TETRAHEDRON LETTERS, (1987), vol. 28, page 3225 | - LOOTS ET AL., Peptides: Chemistry and Biology, ESCOM SCIENCE PUBLISHERS, (1988), page 118 | - BARTH ET AL., ACTA BIOL MED GERM, (1974), vol. 32, page 157 | - WOLF ET AL., ACTA BIO MES GERM, (1972), vol. 37, page 409 | - PUSCHEL ET AL., EUR J BIOCHEM, (1982), vol. 126, page 359 | - DEACON ET AL., DIABETES, (1995), vol. 44, pages 1126 - 1131 | - BERGE ET AL., "Pharmaceutical Salts", J. PH ARM. SCI., (1977), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 | - MATTESON ET AL., ORGANOMETALLICS, (1984), vol. 3, page 1284 | - ANDERSON ET AL., J. AM. CHEM. SOC., (1984), vol. 89, page 5012 | - KETTNER ET AL., J. BIOL. CHEM., (1984), vol. 259, page 15106 | - KINDER ET AL., J. MED. CHEM., vol. 28, page 1917 | WO1994GB02615 | WO1999US02294 |